Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLCMarcelo V. Negrão, Sandip Pravin Patel, Neal S. Akhave et al.|Cancer Discovery|2023Cited by 181
Mechanisms of Response and Tolerance to Active RAS Inhibition in <i>KRAS</i> -Mutant Non–Small Cell Lung CancerHaniel A. Araújo, Ferdinandos Skoulidis|Cancer Discovery|2024Cited by 60